Literature DB >> 15176892

High-titer adenovirus vector production in 293S cell perfusion culture.

Valérie Cortin1, Jules Thibault, Danielle Jacob, Alain Garnier.   

Abstract

Human 293S cells culture for recombinant adenovirus production is traditionally carried out in batch at a maximum of 6 x 10(5) cells/mL. A previous report demonstrated that fed-batch, applied to the adenovirus/293S cells system, improves the volumetric production of viral proteins by increasing the cell density at which cells can be infected, up to 2 x 10(6) cells/mL, without reducing the per-cell yield of product. To increase this cell density limit, the adenovirus production was performed in a perfusion system where the cells were separated by means of a tangential flow filtration device. 293S cell growth to 14 x 10(6) cells/mL was achieved in 10 days, at a medium renewal rate of 1 volume of medium per reactor volume and day (VVD). For adenovirus production, three 293S cell cultures were perfused at 1 VVD in parallel and infected at an average density of 8 x 10(6) cells/mL. One of the cultures was set at 37 degrees C and the two others at 35 degrees C. After a rapid initial cell loss, the average cell density stabilized at 5.75 x 10(6) cells/mL, 12 h postinfection, which was 8 times higher than the cell density in the batch control. This allowed the production of 3.2 x 10(9) infectious viral particles/mL (IVP/mL) at 37 degrees C and 7.8 x 10(9) IVP/mL at 35 degrees C, this last result being 5.5 times higher than the control. To our knowledge, this nonconcentrated titer is the highest value that has ever been published for adenovirus vector production. These observations lead to the conclusion that perfusion is an efficient tool to maintain, at high cell density, a specific production rate level sufficient to increase significantly the adenovirus volumetric production. Furthermore, it shows that perfusion at 35 degrees C can improve viral titer by 2.4-fold compared to 37 degrees C, in accordance with a previous study on adenovirus batch production.

Entities:  

Mesh:

Year:  2004        PMID: 15176892     DOI: 10.1021/bp034237l

Source DB:  PubMed          Journal:  Biotechnol Prog        ISSN: 1520-6033


  12 in total

1.  An efficient method of directly cloning chimpanzee adenovirus as a vaccine vector.

Authors:  Dongming Zhou; Xiangyang Zhou; Ang Bian; Hua Li; Heng Chen; Juliana C Small; Yan Li; Wynetta Giles-Davis; Zhiquan Xiang; Hildegund C J Ertl
Journal:  Nat Protoc       Date:  2010-10-14       Impact factor: 13.491

2.  Cell culture processes for the production of viral vectors for gene therapy purposes.

Authors:  James N Warnock; Otto-Wilhelm Merten; Mohamed Al-Rubeai
Journal:  Cytotechnology       Date:  2006-06-30       Impact factor: 2.058

3.  Adenovirus vector production using low-multiplicity infection of 293 cells.

Authors:  Kentaro Yamada; Naoya Morishita; Tomohisa Katsuda; Shuji Kubo; Akinobu Gotoh; Hideki Yamaji
Journal:  Cytotechnology       Date:  2009-07-08       Impact factor: 2.058

4.  Immobilization of 293 cells using porous support particles for adenovirus vector production.

Authors:  Naoya Morishita; Tomohisa Katsuda; Shuji Kubo; Akinobu Gotoh; Hideki Yamaji
Journal:  Cytotechnology       Date:  2010-02-06       Impact factor: 2.058

5.  Effective modifications for improved homologous recombination and high-efficiency generation of recombinant adenovirus-based vectors.

Authors:  Chengxiang Wu; Vivek R Nerurkar; Richard Yanagihara; Yuanan Lu
Journal:  J Virol Methods       Date:  2008-09-11       Impact factor: 2.014

6.  Effect of p27mt gene on apoptosis of the colorectal cancer cell line Lovo.

Authors:  Jun Chen; Wu-Hua Ding; Shao-Yong Xu; Jia-Ning Wang; Yong-Zhang Huang; Chang-Sheng Deng
Journal:  World J Gastroenterol       Date:  2009-06-14       Impact factor: 5.742

7.  Very high density of CHO cells in perfusion by ATF or TFF in WAVE bioreactor™. Part I. Effect of the cell density on the process.

Authors:  Marie-Françoise Clincke; Carin Mölleryd; Ye Zhang; Eva Lindskog; Kieron Walsh; Véronique Chotteau
Journal:  Biotechnol Prog       Date:  2013-05-21

Review 8.  Bioreactors for high cell density and continuous multi-stage cultivations: options for process intensification in cell culture-based viral vaccine production.

Authors:  Felipe Tapia; Daniel Vázquez-Ramírez; Yvonne Genzel; Udo Reichl
Journal:  Appl Microbiol Biotechnol       Date:  2016-01-13       Impact factor: 4.813

Review 9.  Newer gene editing technologies toward HIV gene therapy.

Authors:  N Manjunath; Guohua Yi; Ying Dang; Premlata Shankar
Journal:  Viruses       Date:  2013-11-14       Impact factor: 5.048

Review 10.  Elements in the Development of a Production Process for Modified Vaccinia Virus Ankara.

Authors:  Ingo Jordan; Verena Lohr; Yvonne Genzel; Udo Reichl; Volker Sandig
Journal:  Microorganisms       Date:  2013-11-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.